Phone alarms work
[Abstract]2025 Jul 1;16(1):5425
First, there is supporting evidence for the safety of GLP-1RAs across the board of cognitive and mental disorders, as we retrieved very few studies 44,159,181,182,193,205 suggesting worse neuropsychiatric outcomes associated with these medications (Tables 16, Fig
In clinical trials involving different types of stimulants: 0.1% of people who took stimulants had symptoms of psychosis or mania 0% of people who took a placebo (a treatment containing no active drug) had symptoms of psychosis or mania Symptoms of psychosis can include hallucinations, paranoia, and delusions (believing things that arent true)
The AUAs 2020 guidelines underscore the need to consider comorbid conditions in hypogonadism treatment [4], and the EAU guidelines (2021) highlight the potential of pharmacologic agents to influence androgen levels indirectly [13]